{"id":481363,"title":"Qualifying notice for Tagrisso (288417) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:29:53.908000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-tagrisso-288417.html?wbdisable=true","snippet":"Qualifying notice for Tagrisso (288417) Pharmaceutical Drugs Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator 3106B Ottawa ON K1A 0K9 Dossier ID: e182735 Control number: 288417 AstraZeneca Canada Inc c/o [name of employee removed] Regulatory…","rawSnapshotUrl":"/api/snapshots/raw/481363","browseUrl":"https://replay.healtharchive.ca/job-6/20260106162953/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-tagrisso-288417.html?wbdisable=true#ha_snapshot=481363","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}